MENU
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vir Biotechnology (VIR) Earnings Date & Reports

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

A.I. Advisor
published Earnings

VIR is expected to report earnings to rise 13.97% to -86 cents per share on May 01

Vir Biotechnology VIR Stock Earnings Reports
Q1'25
Est.
$-0.87
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.51
Q2'24
Missed
by $0.13
Q1'24
Beat
by $0.57
The last earnings report on February 26 showed earnings per share of -75 cents, beating the estimate of -87 cents. With 1.17M shares outstanding, the current market capitalization sits at 888.69M.
View a ticker or compare two or three
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio